Overview
Current NAV
43.8730
As on 15-Sep-2025
Fund Size
3,106.924 Cr
Managed by Vinit Sambre
Expense Ratio
0.59%
Latest reported
Exit Load Rules
2
Conditions apply
Scheme Snapshot
This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 30-Nov-2018. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.
Data shown is for informational purposes only and may be delayed.
Returns
Green = Positive, Red = Negative| Period | Absolute % | CAGR % | Category % | Index % |
|---|---|---|---|---|
| 1D | -0.04 | — | — | — |
| 1W | 0.44 | — | — | — |
| 1M | -0.04 | — | — | — |
| 3M | 3.48 | — | 2.64 | — |
| 6M | 10.43 | — | 13.26 | — |
| 1Y | -1.64 | — | -0.57 | — |
| 3Y | 25.83 | 25.83 | 23.49 | — |
| 5Y | 19.73 | 19.73 | 17.86 | — |
| 10Y | — | — | — | — |
Top Holdings
Portfolio Allocation (Top 8+)
Company
Nature
Sector
% of Corpus
Cipla Ltd.
EQ
Healthcare
9.16
Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
7.88
Ipca Laboratories Ltd.
EQ
Healthcare
7.56
Cohance Lifesciences Ltd.
EQ
Healthcare
7.38
Laurus Labs Ltd.
EQ
Healthcare
6.12
Gland Pharma Ltd.
EQ
Healthcare
5.55
Apollo Hospitals Enterprise Ltd.
EQ
Healthcare
4.77
Globus Medical Inc
EQ
Healthcare
4.66
Illumina Inc. (USA)
EQ
Healthcare
4.53
Sai Life Sciences Ltd.
EQ
Healthcare
4.52
Alembic Pharmaceuticals Ltd.
EQ
Healthcare
4.31
Kovai Medical Center & Hospital Ltd.
EQ
Healthcare
3.37
Analysis Highlights
CONS
1Y annualised returns lower than category average by 0.87%
PROS
Lower expense ratio: 0.59%
PROS
3Y and 5Y annualised returns higher than category average
Exit Load
- Exit load of 0.50% if redeemed within 1 month.2023-08-01
- Exit load of 1% if redeemed within 12 months.2018-11-12